Federal Register Notice

44630

Federal Register / Vol. 83, No. 170 / Friday, August 31, 2018 / Notices

Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–19012 Filed 8–30–18; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–18–16JO; Docket No. CDC–2018–
0077]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Pregnancy Risk Assessment
Monitoring System (PRAMS). PRAMS
provides an important supplement to
vital records data by providing statespecific information not available
through birth certificate data on
maternal behaviors and experiences
before, during and after pregnancy on
health conditions, prenatal care,
postpartum care, access to care, and
health insurance status.
DATES: CDC must receive written
comments on or before October 30,
2018.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–201x–
xxxx by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.

daltland on DSKBBV9HB2PROD with NOTICES

SUMMARY:

VerDate Sep<11>2014

18:42 Aug 30, 2018

Jkt 244001

Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
The Pregnancy Risk Assessment
Monitoring System (PRAMS)—Existing
Collection in Use without an OMB
Control Number—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).

PO 00000

Frm 00069

Fmt 4703

Sfmt 4703

Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) seeks OMB approval
to collect information through the
Pregnancy Risk Assessment Monitoring
System (PRAMS) for three years as a
generic clearance. OMB approval for
new modules will be submitted through
the part of generic clearance
mechanism.
PRAMS supplements vital records
data by providing state-specific
information on maternal behaviors and
experiences before, during and after
pregnancy. Every month, in each
participating state, a sample of women
who have recently given birth to a live
born or stillborn infant is selected from
birth certificates or fetal death files. The
sample is stratified based on the state’s
population of interest to ensure highrisk populations are represented in the
data. PRAMS is a state customized mail
and telephone survey conducted in 51
sites and covers 83% of all live births
in the United States. Information is
collected by self-administered mail
survey with telephone follow-up for
non-responders. Because PRAMS uses
standardized data collection methods, it
allows data to be compared among
states.
The PRAMS survey instrument is
based on a core set of questions
common across all states. Core
questions request information that is not
available from vital records; information
about health conditions, prenatal care,
postpartum care, access to care, or
health insurance status; information
about contraception, health habits or
risk behaviors; and information about
other topics such as breastfeeding. In
addition, CDC provides participating
states with standard questions from
optional modules that states may use to
customize survey content for their
specific needs at the beginning of each
Phase of data collection. In addition, on
occasion, states may be funded to
address emerging topics of interest to
collect supplemental data on optional
modules of interest. These questions can
be used to address state-specific
priorities and special topics such as, for
example, substance use, including
prescription and illicit opioid use,
disease epidemics, or other topics
related to healthy pregnancy; these
supplements can be administered to
women identified in the usual manner
or via hospital records. States not
intending to implement the survey on
an ongoing basis, can instead employ a
point-in-time survey. Because PRAMS
infrastructure was developed to access a
specific and vulnerable subpopulation,
the PRAMS infrastructure can be

E:\FR\FM\31AUN1.SGM

31AUN1

44631

Federal Register / Vol. 83, No. 170 / Friday, August 31, 2018 / Notices
rapidly adapted for targeted information
collection that would not be feasible
with other surveillance methods.
The burden estimate for PRAMS
includes two types of information

collection: (1) Information collection
associated with the PRAMS core
questions and predetermined standard
questions from optional modules, and
(2) information collection associated

with optional modules for emerging
issues. Participation is voluntary and
there are no costs to respondents other
than their time.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Average hours
per response
(in hours)

62,514

1

25/60

26,048

PRAMS Standard Questions on optional modules—predetermined.
Estimated burden hours for additional optional modules—emerging.

62,514

1

10/60

10,419

32,530

1

7/60

3,795

...........................................................

........................

........................

........................

40,262

Types of
respondents

Form name

Women who recently delivered a live
birth.

PRAMS Phase 8 Core Questions ....

Total ...........................................

Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–19014 Filed 8–30–18; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–0800]

daltland on DSKBBV9HB2PROD with NOTICES

Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Focus Group
Testing to Effectively Plan and Tailor
Cancer Prevention and Control
Communication Campaigns to the Office
of Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on December
13, 2017 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including

VerDate Sep<11>2014

18:42 Aug 30, 2018

Jkt 244001

Number of
respondents

whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Focus Group Testing to Effectively
Plan and Tailor Cancer Prevention and
Control Communication Campaigns—
(OMB No. 0920–0800, exp. 12/31/
2017)—Reinstatement without Change—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).

PO 00000

Frm 00070

Fmt 4703

Sfmt 4703

Total burden
hours

Background and Brief Description
CDC requests a reinstatement of the
information collection with OMB
Control Number 0920–0800. The
mission of the CDC’s Division of Cancer
Prevention and Control (DCPC) is to
reduce the burden of cancer in the
United States through cancer
prevention, reduction of risk, early
detection, better treatment, and
improved quality of life for cancer
survivors. Toward this end, the DCPC
supports the scientific development and
implementation of various health
communication campaigns with an
emphasis on specific cancer burdens.
This process requires testing of
messages, concepts, and materials prior
to their final development and
dissemination, as described in the
second step of the health
communication process. The health
communication process is a scientific
model developed by the U.S.
Department of Health and Human
Services’ National Cancer Institute to
guide sound campaign development.
The communication literature supports
various data collection methods, one of
which is focus groups, to conduct
credible formative, concept, message,
and materials testing. The purpose of
focus groups is to ensure that the public
and other key audiences, like health
professionals, clearly understand
cancer-specific information and
concepts, are motivated to take the
desired action, and do not react
negatively to the messages. CDC is
currently approved to collect
information needed to plan and tailor
cancer communication campaigns (OMB
No. 0920–0800, exp. 12/31/2017), and
seeks OMB approval to reinstate this
generic clearance.
Information collection will involve
focus groups to assess numerous

E:\FR\FM\31AUN1.SGM

31AUN1